In a groundbreaking move that has left the pharmaceutical sector buzzing, the Board of Directors of Ind-Swift Laboratories Limited (“Ind-Swift”) announced the blockbuster sale of its active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS) divisions to Synthimed Labs Private Limited (“Synthimed”) on September 6, 2023. The mega-deal, valued at a whopping INR […]
The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate’s pharma business – Piramal Pharma. The US-based private equity firm will carry out the acquisition through CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, which is an […]
Piramal Pharma Solutions has agreed to acquire the solid oral dosage drug product manufacturing facility of G&W Laboratories in Sellersville, Pennsylvania for an undisclosed price. A subsidiary of India-based conglomerate Piramal Enterprises, the company is a contract development and manufacturing organization (CDMO), which provides end-to-end development and manufacturing solutions across the drug life cycle. According […]